BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31349867)

  • 1. ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months.
    McTier TL; Kryda K; Wachowski M; Mahabir S; Ramsey D; Rugg D; Mazaleski M; Therrien C; Adams E; Wolff T; Bowman DD
    Parasit Vectors; 2019 Jul; 12(1):369. PubMed ID: 31349867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of ProHeart
    Bowman DD; McTier TL; Adams EL; Mahabir SP; Login JA; Bidgood T; Woods DJ
    Parasit Vectors; 2017 Nov; 10(Suppl 2):502. PubMed ID: 29143654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.
    Kryda K; Six RH; Walsh KF; Holzmer SJ; Chapin S; Mahabir SP; Myers M; Inskeep T; Rugg J; Cundiff B; Pullins A; Ulrich M; McCall JW; McTier TL; Maeder SJ
    Parasit Vectors; 2019 Sep; 12(1):445. PubMed ID: 31506094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative preventive efficacy of ProHeart
    McTier TL; Holzmer S; Kryda K; Mahabir S; McCall JW; Trombley J; Maeder SJ
    Parasit Vectors; 2021 Apr; 14(1):226. PubMed ID: 33902689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfilarial reduction following ProHeart® 6 and ProHeart® SR-12 treatment in dogs experimentally inoculated with a resistant isolate of Dirofilaria immitis.
    McTier TL; Pullins A; Inskeep GA; Gagnon G; Fan H; Schoell A; Bidgood T; Login J; Meeus P
    Parasit Vectors; 2017 Nov; 10(Suppl 2):485. PubMed ID: 29143650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
    Kryda K; Holzmer S; Everett WR; McCall JW; Mahabir SP; McTier TL; Maeder SJ
    Parasit Vectors; 2020 Jul; 13(1):339. PubMed ID: 32660542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive efficacy of six monthly oral doses of Simparica Trio
    Myers JAE; Holzmer S; McCall JW; Mahabir SP; McTier TL; Maeder SJ; Kryda K
    Parasit Vectors; 2022 Mar; 15(1):81. PubMed ID: 35277191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs.
    McTier TL; Six RH; Pullins A; Chapin S; McCall JW; Rugg D; Maeder SJ; Woods DJ
    Parasit Vectors; 2017 Nov; 10(Suppl 2):482. PubMed ID: 29143634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs.
    Alberigi B; Fernandes JI; Paiva JP; Mendes-de-Almeida F; Knackfuss F; Merlo A; Labarthe N
    Parasit Vectors; 2020 Oct; 13(1):503. PubMed ID: 33023664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs.
    McTier TL; Six RH; Pullins A; Chapin S; Kryda K; Mahabir SP; Woods DJ; Maeder SJ
    Parasit Vectors; 2019 Sep; 12(1):444. PubMed ID: 31506088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi
    Bowman DD; Ohmes CM; Hostetler JA; Keil DJ; Settje TL; Charles SD
    Parasit Vectors; 2017 Nov; 10(Suppl 2):478. PubMed ID: 29143660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio
    Young LM; Wiseman S; Crawley E; Wallace K; Snyder DE
    Parasit Vectors; 2021 May; 14(1):284. PubMed ID: 34044864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an injectable, sustained-release formulation of moxidectin in preventing experimental heartworm infection in mongrel dogs challenged 12 months after administration.
    Lok JB; Knight DH; Nolan TJ; Grubbs ST; Cleale RM; Heaney K
    Vet Parasitol; 2005 Mar; 128(1-2):129-35. PubMed ID: 15725542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analyses of heartworm (Dirofilaria immitis) disease and ectoparasite preventive medication compliance in veterinary practices in the USA.
    Mwacalimba K; Sears D; Brennan C; Poulsen Nautrup B; Sheehy J; Smith K; Adolph C
    Parasit Vectors; 2023 Apr; 16(1):149. PubMed ID: 37106437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
    Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
    Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs.
    Bowman DD; Grazette AR; Basel C; Wang Y; Hostetler JA
    Parasit Vectors; 2016 Jan; 9():12. PubMed ID: 26746229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month prophylactic efficacy of moxidectin sustained release (SR) injectable for dogs against experimental heartworm infection in growing puppies.
    Lok JB; Washabau RJ; Heaney K; Nolan TJ; Hendrick MJ; Neumann NR; Ulrich M
    Vet Parasitol; 2005 Oct; 133(2-3):233-41. PubMed ID: 16085364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance.
    Savadelis MD; McTier TL; Kryda K; Maeder SJ; Woods DJ
    Parasit Vectors; 2022 Mar; 15(1):82. PubMed ID: 35277180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis.
    Lok JB; Knight DH; Wang GT; Doscher ME; Nolan TJ; Hendrick MJ; Steber W; Heaney K
    Am J Vet Res; 2001 Nov; 62(11):1721-6. PubMed ID: 11703014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing incidence of Dirofilaria immitis in dogs in USA with focus on the southeast region 2013-2016.
    Drake J; Wiseman S
    Parasit Vectors; 2018 Jan; 11(1):39. PubMed ID: 29343304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.